Header Logo

Connection

Naoko Takebe to Heterografts

Back to Details
This is a "connection" page, showing publications Naoko Takebe has written about Heterografts.
Naoko Takebe
Connection Strength
0.055
Heterografts
  1. Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts. Cancer Res Commun. 2024 03 19; 4(3):834-848.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.